BridgeMD
New treatment option for Robotic Surgical Procedures
Official title Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery
ClinicalTrials.gov ID: NCT07332806
What this study is testing
- What it's testing
- This study aims to evaluate the impact of different extubation strategy on the occupancy time of operating room (OR) and the incidence of adverse events and quality of recovery after robotic-assisted surgery. The investigators hypothesize that extubation in the post-anesthesia care unit (PACU) may reduce OR occupancy time without increasing adverse events or worsening quality of recovery early after robotic-assisted surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged ≥18 years;
- Scheduled to undergo elective robot-assisted laparoscopic surgery under general anesthesia;
- Expected tracheal extubation during daytime working hours (before 4:00 PM).
You likely can't join if
- Refuse to participate in the study;
- Morbid obesity (body mass index ≥35 kg/m²);
- Preoperatively diagnosed obstructive sleep apnea, or patients with a STOP-Bang score ≥3 in combination with serum bicarbonate (HCO₃-) ≥28 mmol/L;
- Patients at high risk of difficult airway (anticipated difficult intubation and/or extubation during preoperative assessment);
- Preexisting sick sinus syndrome, severe sinus bradycardia (heart rate \< 50 beats/min), or second-degree or higher atrioventricular block without...
- Significant pulmonary function impairment (FEV₁/FVC ratio \< 70%, and total lung capacity [TLC] and vital capacity [VC] \< 80% of predicted values);
See the full eligibility criteria
- Aged ≥18 years;
- Scheduled to undergo elective robot-assisted laparoscopic surgery under general anesthesia;
- Expected tracheal extubation during daytime working hours (before 4:00 PM).
- Refuse to participate in the study;
- Morbid obesity (body mass index ≥35 kg/m²);
- Preoperatively diagnosed obstructive sleep apnea, or patients with a STOP-Bang score ≥3 in combination with serum bicarbonate (HCO₃-) ≥28 mmol/L;
- Patients at high risk of difficult airway (anticipated difficult intubation and/or extubation during preoperative assessment);
- Preexisting sick sinus syndrome, severe sinus bradycardia (heart rate \< 50 beats/min), or second-degree or higher atrioventricular block without pacemaker implantation; congenital heart disease with any type of...
- Significant pulmonary function impairment (FEV₁/FVC ratio \< 70%, and total lung capacity [TLC] and vital capacity [VC] \< 80% of predicted values);
- Severe hepatic dysfunction (Child-Pugh class C); severe renal dysfunction (estimated glomerular filtration rate \< 30 mL/min/1.73 m²); or American Society of Anesthesiologists (ASA) physical status classification ≥IV;
- Preoperative diagnoses of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis;
- Inability to communicate due to coma, severe dementia, or language impairment;
- Planned postoperative admission to the intensive care unit;
- Any other conditions that are deemed for study participation.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.